-
My Account
In App
My Account
| Open | 1,810.00 |
| Previous Close | 1,857.20 |
| Volume | 1,155.00 |
| Value (Lacs) | 21.43 |
| VWAP | 1,848.44 |
| Beta | |
| Mkt Cap (Rs. Cr.) | 1,873 |
| High | 1,873.95 |
| Low | 1,810.00 |
| UC Limit | 2,228.60 |
| LC Limit | 1,485.80 |
| 52 Week High | 2,215.24 |
| 52 Week Low | 1,429.52 |
| Face Value | 10.00 |
| All Time High | 2,215.24 |
| All Time Low | 35.24 |
| 20D Avg Volume | 3,218 |
| 20D Avg Delivery(%) | 75.38 |
| Book Value Per Share | 179.17 |
| Dividend Yield | 0.00 |
| TTM EPS See historical trend | 42.02 (-33.22% YoY) |
| TTM PE See historical trend | 44.15 (High PE) |
| P/B See historical trend | 10.36 (High P/B) |
| Sector PE | 39.72 |
*Delayed by 20 seconds.
Stock Score
Get detailed analysis with Moneycontrol Stock Insights.
| Moving Averages | -- |
| Technical Indicators | -- |
| Moving Averages Crossovers | -- |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| Days | |
|---|---|
| 5 | - - |
| 10 | - - |
| 20 | - - |
| 50 | - - |
| 100 | - - |
| 200 | - - |
| Moving Averages | -- |
| Technical Indicators | -- |
| Moving Averages Crossovers | -- |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| Days |
|---|
| Moving Averages | -- |
| Technical Indicators | -- |
| Moving Averages Crossovers | -- |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| Days |
|---|
| 1 Week | --% | |
| 1 Month | --% | |
| 3 Months | --% | |
| YTD | --% | |
| 1 Year | --% | |
| 3 Years | --% |
5 out of 8 years Beta Drugs has given positive returns in November.
| Month | Max. Positive Change(%) | Avg. Positive Change(%) | Max. Negative Change(%) | Avg. Negative Change(%) | Average Change(%) |
|---|---|---|---|---|---|
| November | 51.15% (2017) | 20.08% | -17.36% (2019) | -7.64% | 9.69% |
Beta Drugs receives DCGI nod for Methotrexate Oral Solution Beta Drugs has received approval from the Drug Controller General of India DCGI for the launch of Methotrexate Solution for Oral Use. View more
Posted by : kamal20
Posted by : The Fixed Income
Repost this message
Build Steady Wealth with a Secured NBFC Bond Investment VIVRITI CAPITAL LIMITED 2027 ✔️ Coupon: 9.15% ✔️ Rating: CARE A+ Stable ✔️ Tenor: 2y (Maturity: 04/Nov/2027) Senior Secured Bond | NBFC Bond | High Return Bond | Listed This bond offers investors the opportunity to earn steady returns while maintaining a conservative risk profile. ???? Explore on The Fixed Income: https://www.thefixedincome.com/product/dVJhbmJ3PT0=/915-vivriti-capital-limited-2027?utm_source=Moneycontrol&utm_medium=Forum&utm_campaign=Product_list
*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.
*A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.
| Date | Agenda |
|---|
| Ex-Date | Type | Dividend (Rs) |
|---|
| Announcement Date | Ex-Bonus | Ratio |
|---|
| Ex-Split | Old FV | New FV |
|---|
| Ex-Right | Ratio | Premium |
|---|
| Date | Agenda |
|---|
| Company Name | Price | % Chg | MCap(Cr) | TTM PE | P/B | ROE(%) | 1 Yr Perform(%) | Net Profit(Rs.) | Net Sales(Rs.) | Debt to Equity |
|---|---|---|---|---|---|---|---|---|---|---|
| Beta Drugs | 1,855.00 | -0.12 | 1,872.54 | 121.32 | 14.56 | 11.95 | 1.63 | 15 | 220 | 0.96 |
| Sun Pharma | 1,690.70 | -0.75 | 405,655.56 | 39.11 | 5.62 | 15.13 | -8.56 | 10,980 | 52,578 | 0.03 |
| Divis Labs | 6,738.00 | 1.25 | 178,872.73 | 77.56 | 11.95 | 14.63 | 14.40 | 2,191 | 9,360 | 0.00 |
| Cipla | 1,501.30 | -2.52 | 121,270.69 | 22.49 | 4.28 | 16.90 | -3.25 | 5,291 | 27,547 | 0.00 |
| Torrent Pharma | 3,560.10 | -1.17 | 120,489.96 | 60.19 | 16.06 | 25.17 | 11.16 | 1,911 | 11,516 | 0.40 |
Sharpest Opinions & Actionable Insights 
Exclusive Webinars 
Research & Expert Technical Analysis 
